FOX Corporation (NASDAQ:FOXA) strengthens multi-platform media operations, often appearing in discussions tied to the nasdaq ...
Celldex (NASDAQ:CLDX) announced today the initiation of its global Phase 3 trial (EMBARQ-ColdU and SD) designed to establish the efficacy and safety of barzolvolimab in adult patients with cold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback